Skip to content
Search

Latest Stories

Boots pharmacist claim of harassment related to race

A recent employment tribunal has affirmed a pharmacist's allegation of racial harassment during his employment at Boots, especifically citing an incident that occurred in July 2020

An employment tribunal has ruled in favour of a pharmacist, Samson Famojuro, who claimed he faced racial harassment during his tenure at Boots pharmacy.


The decision comes after a five-day hearing earlier this year, where the tribunal found that Famojuro, of Nigerian origin and working as the Responsible Pharmacist at Boots’ Silva Island Way branch in Wickford, Essex, was subjected to race-related treatment by pre-registration pharmacy technician Emma Walker in July 2020.

The tribunal criticized the "inconsistent and untruthful evidence" presented by Walker and pharmacy adviser Nicole Daley during the proceedings.

It suggested that their "repeated allegations of aggression" against Famojuro could lead to the conclusion that they were stereotyping him "as an aggressive black man when all he was doing was seeking to assert his authority."

While the tribunal dismissed some claims of harassment and direct race discrimination, it upheld Famojuro's claim for unfair constructive dismissal.

The incident occurred on July 18, 2020, when Walker and Daley, both in junior positions to Famojuro, allegedly undermined his authority as the Responsible Pharmacist.

Famojuro requested assistance with filing bagged items and prescriptions, but tensions arose when Daley refused, insisting filing was solely the responsibility of the pharmacist. Further disputes emerged when Famojuro realized labelling errors on bags, and Daley refused to correct them.

Subsequent events, including handling a prescription for an Asian patient and a confrontation in the staff room, led to Famojuro feeling undermined and unsafe.

The tribunal noted inconsistencies and untruths in Walker and Daley's evidence, highlighting their cooperation on statements and a tendency to make fresh allegations when flaws were pointed out.

The pharmacist was eventually asked to leave by Walker, supported by branch manager Amy Munson, who reportedly did not investigate the situation thoroughly.

The tribunal concluded that Walker, Daley, and Munson "escalated the situation" to the point where they turned against Famojuro.

It expressed concern over the "inconsistent and untruthful evidence," suggesting racial stereotyping by Walker and Daley. Boots' investigation into the allegations was criticized for not adequately exploring whether race played a role.

Boots responded to the ruling, stating, "At Boots, we stand firmly against workplace harassment of any kind. We are reviewing the court’s findings and will reflect and take action on any learnings."

The tribunal's decision sheds light on the importance of thorough workplace investigations and the potential consequences of racial stereotyping in professional settings.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less